Pixium Vision - Successful Prima activation in first patient
Pixium announced on 25 January 2018 the first human activation of the Prima wireless photovoltaic sub-retinal implant, following successful...
56 Views
Pixium cleared to start EU Prima feasibility study
Pixium has received clearance from the French regulatory agency (Agence Nationale de Sécurité du Médicament et des Produits de Santé, or ANSM) to...
65 Views
Pixium seeks to address short Iris II lifespan
Pixium Vision recently reported data from its 10-patient Iris II study showing that it improves visual performance, but stops operating as intended...
66 Views
Key Iris II and Prima catalysts for H217
Pixium is building up a sales channel across Europe for its Iris II device, and is working on securing reimbursement and generating initial product...
74 Views
Forfait Innovation decision postponed
Pixium announced on 24 May 2017 that the French Haute Autorité de Santé (HAS) has requested additional clinical data before agreeing to provide...
47 Views